Long-term [tmco]
Safety [hcpp]
Efficacy [qlco]
Combination [qlco]
Gemfibrosil [lipd, phsu]
HMG-CoA [bacs, orch]
Reductase [aapp, enzy]
inhibitors [chvf]
treatment [ftcn]
Mixed [ftcn]
lipid disorders [dsyn]
Background [cnce]
Combinations [mnob]
Gemfibrosil [lipd, phsu]
I- [inch]
Show [inpr]
promise [idcn]
treating [topp]
Mixed [ftcn]
Lipid [lipd]
Abnormalities [cgab]
Concern [idcn]
Risk [qlco]
Myopathy [dsyn]
Hepatic [blor]
toxicity [qlco]
Limited [ftcn]
Combination [qlco]
To [qlco]
Long-term [tmco]
Safety [hcpp]
Efficacy [qlco]
Combination [qlco]
Identified [qlco]
Patients [podg]
Place [spco]
Combination [qlco]
Gemfibrosil [lipd, phsu]
Reductase [aapp, enzy]
Inhibitor [qlco]
Methods [inpr]
Pravastatin [orch, phsu]
Simvastatin [orch, phsu]
fluvastatin [orch, phsu]
Lovastatin [orch, phsu]
atorvastatin [orch, phsu]
Incremental [qnco]
Doses [qnco]
Combined [qlco]
Gemfibrosil [lipd, phsu]
mg% [qnco]
Twice daily [tmco]
Lipid [lipd]
Profile [lbpr]
creatine kinase levels [fndg]
Aminotransferase [aapp, enzy]
monitor [hlca]
Two Hundred Fifty [qnco]
Patients [podg]
Established [qlco]
Atherosclerosis [dsyn]
Receive [qlco]
Combination Therapy [topp]
Mean [qnco]
Span [cnce]
monitor [hlca]
Result [ftcn]
Patients [podg]
Gemfibrosil [lipd, phsu]
Started [qlco]
Added [ftcn]
Pretreatment [sbst]
Level [qlco]
Fall [fndg]
mg dl [qnco]
mg dl [qnco]
P NOS [aapp, imft]
Combination Therapy [topp]
Cholesterol, HDL [bacs, lipd]
Level [qlco]
Rose [plnt]
mg dl [qnco]
mg dl [qnco]
P NOS [aapp, imft]
Triglyceride level [lbtr]
Fall [fndg]
mg dl [qnco]
mg dl [qnco]
P NOS [aapp, imft]
Ratio [qnco]
Total Cholesterol [lbpr]
Fall [fndg]
P NOS [aapp, imft]
Patients [podg]
Begin [tmco]
Gemfibrosil [lipd, phsu]
Added [ftcn]
Pretreatment [sbst]
Total Cholesterol [lbpr]
Level [qlco]
Fall [fndg]
mg dl [qnco]
mg dl [qnco]
Combination Therapy [topp]
P NOS [aapp, imft]
Level [qlco]
Rose [plnt]
mg dl [qnco]
mg dl [qnco]
P NOS [aapp, imft]
Triglyceride level [lbtr]
Fall [fndg]
mg dl [qnco]
mg dl [qnco]
P NOS [aapp, imft]
Ratio [qnco]
Total Cholesterol [lbpr]
Fall [fndg]
P NOS [aapp, imft]
Group [idcn]
Lipid [lipd]
Profile [lbpr]
Combination Therapy [topp]
Better [qlco]
Obtained [ftcn]
Single [popg]
Agent [chvf]
therapy [ftcn]
One [qnco]
Episode [tmco]
Myopathy [dsyn]
One [qnco]
Episode [tmco]
Aminotransferase [aapp, enzy]
Level [qlco]
Elevation [topp]
time limit [tmco]
Upper [spco]
Normal [qlco]
Occurred [acty]
Resolved [idcn]
Cessation [acty]
therapy [ftcn]
Consequence [ftcn]
Conclusions [idcn]
Combinations [mnob]
Gemfibrosil [lipd, phsu]
Compared [acty]
Agent [chvf]
Alone [qnco]
Result [ftcn]
Improved [qlco]
Long-term [tmco]
Control [grup]
Lipid [lipd]
Abnormalities [cgab]
Mixed [ftcn]
lipid disorders [dsyn]
low [qlco]
Incidence [qnco]
toxicity [qlco]
Permit [rnlw]
Combination Therapy [topp]
Patients [podg]
High Risk [qlco]
atherosclerotic [ftcn]
Complications [patf]
